However, patients with breast cancer aged less than 40 years with the BRCA1 pathogenic variant in exons 1-10 in stage I who underwent RRBM + RRBSO had an almost similar impact on survival compared with those who underwent RRBM alone. Here, BRCA1 is linked to breast cancer.